Recent developments and applications of smart nanoparticles in biomedicine
Source abstract
Abstract
Abstract Over the last decades, nanotechnology applied in medicine (nanomedicine) has sparked great interest from the scientific community, thanks to the possibility to engineer nanostructured materials, including nanoparticles (NPs), for a specific application. Their small size confers them unique properties because they are subject to physical laws in the middle between classical and quantum physics. This review is proposed to explain better how to design a specific NP and clarify the relationship between the type, size, and shape of NPs and the specific medical applications. NPs are classified into inorganic (metallic NPs, quantum dots, carbon-based nanostructures, mesoporous silica NPs) and organic (liposomes and micelles, dendrimers, and polymer NPs). Here, we report an accurate description of the potential of each NPs type focusing on their multiple areas of application, including theranostics drug delivery, imaging, tissue engineering, antimicrobial techniques, and nanovaccines. All these features make NPs a promise to revolutionize the new era of nanomedicine.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Graphene and Nanomaterials Applications · Nanoparticle-Based Drug Delivery · Nanoparticles: synthesis and applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Biological, Chemical and Pharmaceutical Sciences and Technologies [STEBICEF], University of Palermo, Viale Delle Scienze , Ed. 16 , 90128 Palermo , Italy
Abiel s.r.l, c/o Arca Incubatore di Imprese, University of Palermo, Viale delle Scienze , Ed. 16 (Floor-2) , 90128 Palermo , Italy
References (100+)
Show source-provided references
1. Shahbazi MA, Faghfouri L, Ferreira MPA, Figueiredo P, Maleki H, Sefat F, et al. The versatile biomedical applications of bismuth-based nanoparticles and composites: Therapeutic, diagnostic, biosensing, and regenerative properties. Chem Soc Rev. 2020;49:1253–321.10.1039/C9CS00283A ↗
2. Taniguchi N. On the basic concept of ‘nano-technology. Proceedings of the International Conference on Production Engineering, Tokyo; 1974.
3. Drexler KE Engines of creation: The coming era of nanotechnology chapter 1: engines of construction. http://www.foresight.org/EOC/EOC_Chapter_1.html. (Accessed 8 February 2021).
4. Scaffaro R, Re GL, Rigogliuso S, Ghersi G. 3D polylactide-based scaffolds for studying human hepatocarcinoma processes in vitro. Sci Technol Adv Mater. 2012 Aug;13:045003. 10.1088/1468-6996/13/4/045003.10.1088/1468-6996/13/4/045003 ↗
5. Pavia FC, La Carrubba V, Ghersi G, Brucato V. Poly-left-lactic acid tubular scaffolds via diffusion induced phase separation: Control of morphology. Polym Eng Sci. 2013;53:431–42.10.1002/pen.23273 ↗
6. Begines B, Ortiz T, Pérez-Aranda M, Martínez G, Merinero M, Argüelles-Arias F, et al. Polymeric nanoparticles for drug delivery: Recent developments and future prospects. Nanomaterials. 2020;10:1–41.10.3390/nano10071403 ↗
7. Pippa N, Gazouli M, Pispas S. Recent advances and future perspectives in polymer-based nanovaccines. Vaccines. 2021 May 26;9:558. 10.3390/VACCINES9060558.10.3390/vaccines9060558 ↗
8. Fatima F, Siddiqui S, Khan WA. Nanoparticles as novel emerging therapeutic antibacterial agents in the antibiotics resistant era. Biol Trace Elem Res. 2021;199:2552–64.10.1007/s12011-020-02394-3 ↗
9. Yuan D, Ellis CM, Davis JJ. Mesoporous silica nanoparticles in bioimaging. Mater (Basel, Switz). 1 September 2020;13(17):3795. 10.3390/MA13173795.10.3390/ma13173795 ↗
10. Lombardo D, Kiselev MA, Caccamo MT. Smart nanoparticles for drug delivery application: development of versatile nanocarrier platforms in biotechnology and nanomedicine. J Nanomater. 2019;2019:1–26. 10.1155/2019/370251810.1155/2019/3702518 ↗
11. Schirrmacher V. From chemotherapy to biological therapy: A review of novel concepts to reduce the side effects of systemic cancer treatment (Review). Int J Oncol. 2019;54:407–19.10.3892/ijo.2018.4661 ↗
12. Ke X, Shen L. Molecular targeted therapy of cancer: The progress and future prospect. Front Lab Med. 2017;1:69–75.10.1016/j.flm.2017.06.001 ↗
13. Jain KK. An overview of drug delivery systems. Methods in molecular biology. Humana New York, NY: Humana Press Inc.; p. 1–54. 10.1007/978-1-4939-9798-5.10.1007/978-1-4939-9798-5_1 ↗
14. Sun T, Zhang YS, Pang B, Hyun DC, Yang M, Xia Y. Engineered nanoparticles for drug delivery in cancer therapy. Angew Chem – Int Ed. 2014;53:12320–64.10.1002/anie.201403036 ↗
15. Yin IX, Zhang J, Zhao IS, Mei ML, Li Q, Chu CH. The antibacterial mechanism of silver nanoparticles and its application in dentistry. Int J Nanomed. 2020;15:2555–62.10.2147/IJN.S246764 ↗
16. Oliveira JM, Sousa RA, Kotobuki N, Tadokoro M, Hirose M, Mano JF, et al. The osteogenic differentiation of rat bone marrow stromal cells cultured with dexamethasone-loaded carboxymethylchitosan/poly(amidoamine) dendrimer nanoparticles. Biomaterials. 2009;30:804–13.10.1016/j.biomaterials.2008.10.024 ↗
17. Lung P, Yang J, Li Q. Nanoparticle formulated vaccines: Opportunities and challenges. Nanoscale. 2020;12:5746–63.10.1039/C9NR08958F ↗
18. Fu X, Cai J, Zhang X, Li WD, Ge H, Hu Y. Top-down fabrication of shape-controlled, monodisperse nanoparticles for biomedical applications. Adv Drug Delivery Rev. 2018;132:169–87.10.1016/j.addr.2018.07.006 ↗
19. Belusso LCS, Lenz GF, Fiorini EE, Pereira AJ, Sequinel R, Bini RA, et al. Synthesis of silver nanoparticles from bottom up approach on borophosphate glass and their applications as SERS, antibacterial and glass-based catalyst. Appl Surf Sci. 2019;473:303–12.10.1016/j.apsusc.2018.12.155 ↗
20. Pareek V, Bhargava A, Gupta R, Jain N, Panwar J. Synthesis and applications of noble metal nanoparticles: a review. Adv Sci Eng Med. 2017;9:527–44.10.1166/asem.2017.2027 ↗
21. Avila-Olias M, Pegoraro C, Battaglia G, Canton I. Inspired by nature: Fundamentals in nanotechnology design to overcome biological barriers. Ther Deliv. 2013;4:27–43.10.4155/tde.12.126 ↗
22. Braakhuis HM, Cassee FR, Fokkens PH, de la Fonteyne LJ, Oomen AG, Krystek P, et al. Identification of the appropriate dose metric for pulmonary inflammation of silver nanoparticles in an inhalation toxicity study. Nanotoxicology. 2016;10:63–73.10.1016/j.toxlet.2016.06.1953 ↗
23. Ibrahim K, Al-Mutary M, Bakhiet A, Khan, Khan HH. Histopathology of the liver, kidney, and spleen of mice exposed to gold nanoparticles. Molecules. 2018;23:1848.10.3390/molecules23081848 ↗
24. De Jong WH, Hagens WI, Krystek P, Burger MC, Sips AJ, Geertsma RE. Particle size-dependent organ distribution of gold nanoparticles after intravenous administration. Biomaterials. 2008;29:1912–9.10.1016/j.biomaterials.2007.12.037 ↗
25. Cabral H, Matsumoto Y, Mizuno K, Chen Q, Murakami M, Kimura M, et al. Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size. Nat Nanotechnol. 2011;6:815–23.10.1038/nnano.2011.166 ↗
26. Liu GW, Pippin JW, Eng DG, Lv S, Shankland SJ, Pun SH, et al. Nanoparticles exhibit greater accumulation in kidney glomeruli during experimental glomerular kidney disease. Physiol Rep. 2020;8:e14545.10.14814/phy2.14545 ↗
27. Zhou Y, Peng Z, Seven ES, Leblanc RM. Crossing the blood-brain barrier with nanoparticles. J Controlled Rel. 2018;270:290–303.10.1016/j.jconrel.2017.12.015 ↗
28. Bose T, Latawiec D, Mondal PP, Mandal S. Overview of nano-drugs characteristics for clinical application: The journey from the entry to the exit point. J Nanopart Res. 2014;16:1–25.10.1007/s11051-014-2527-7 ↗
29. Barbara R, Belletti D, Pederzoli F, Masoni M, Keller J, Ballestrazzi A, et al. Novel Curcumin loaded nanoparticles engineered for Blood-Brain Barrier crossing and able to disrupt Abeta aggregates. Int J Pharm. 2017;526:413–24.10.1016/j.ijpharm.2017.05.015 ↗
30. Hua X, Tan S, Bandara HM, Fu Y, Liu S, Smyth HD, et al. Externally controlled triggered-release of drug from plga micro and nanoparticles. PLoS One. 2014;9:e114271.10.1371/journal.pone.0114271 ↗
31. Cartaxo AL, Costa-Pinto AR, Martins A, Faria S, Gonçalves V, Tiritan ME, et al. Influence of PDLA nanoparticles size on drug release and interaction with cells. J Biomed Mater Res Part A. 2019;107:482–93.10.1002/jbm.a.36563 ↗
32. Mauro N, Campora S, Ada Mo G, Scialabba C, Ghersi G, Giammona, et al. Polyaminoacid-doxorubicin prodrug micelles as highly selective therapeutics for targeted cancer therapy. RSC Adv. 2016;6:77256–66. 10.1039/C6RA14935A.10.1039/C6RA14935A ↗
33. Kou L, Sun J, Zhai Y, He Z. The endocytosis and intracellular fate of nanomedicines: Implication for rational design. Asian J Pharm Sci. 2013;8:1–10.10.1016/j.ajps.2013.07.001 ↗
34. Shaw S, Ganguly S, Sibanda P, Chakraborty S. Dispersion characteristics of blood during nanoparticle assisted drug delivery process through a permeable microvessel. Microvasc Res. 2014;92:25–33.10.1016/j.mvr.2013.12.007 ↗
35. Geng Y, Dalhaimer P, Cai S, Tsai R, Tewari M, Minko T, et al. Shape effects of filaments versus spherical particles in flow and drug delivery. Nat Nanotechnol. 2007;2:249–55.10.1038/nnano.2007.70 ↗
36. Zhao Y, Wang Y, Ran F, Cui Y, Liu C, Zhao Q, et al. A comparison between sphere and rod nanoparticles regarding their in vivo biological behavior and pharmacokinetics. Sci Rep. 2017;7:1–11.10.1038/s41598-017-03834-2 ↗
37. MacParland SA, Tsoi KM, Ouyang B, Ma XZ, Manuel J, Fawaz A, et al. Phenotype determines nanoparticle uptake by human macrophages from liver and blood. ACS Nano. 2017;11:2428–43.10.1021/acsnano.6b06245 ↗
38. Suk JS, Xu Q, Kim N, Hanes J, Ensign LM. PEGylation as a strategy for improving nanoparticle-based drug and gene delivery. Adv Drug Delivery Rev. 2016;99:28–51.10.1016/j.addr.2015.09.012 ↗
39. Patsula V, Horák D, Kučka J, Macková H, Lobaz V, Francová P, et al. Synthesis and modification of uniform PEG-neridronate-modified magnetic nanoparticles determines prolonged blood circulation and biodistribution in a mouse preclinical model. Sci Rep. 2019;9:1–12.10.1038/s41598-019-47262-w ↗
40. Xue W, Liu Y, Zhang N, Yao Y, Ma P, Wen H, et al. Effects of core size and PEG coating layer of iron oxide nanoparticles on the distribution and metabolism in mice. Int J Nanomed. 2018;13:5719–31.10.2147/IJN.S165451 ↗
41. Rodriguez PL, Harada T, Christian DA, Pantano DA, Tsai RK, Discher DE. Minimal ‘self’ peptides that inhibit phagocytic clearance and enhance delivery of nanoparticles. Sci (80-). 2013;339:971–5.10.1126/science.1229568 ↗
42. Parodi A, Quattrocchi N, Van De Ven AL, Chiappini C, Evangelopoulos M, Martinez JO, et al. Synthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functions. Nat Nanotechnol. 2013;8:61–8.10.1038/nnano.2012.212 ↗
43. Hu CM, Zhang L, Aryal S, Cheung C, Fang RH, Zhang L. Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform. Proc Natl Acad Sci U S A. 2011;108:10980–5.10.1073/pnas.1106634108 ↗
44. Sharma G, Valenta DT, Altman Y, Harvey S, Xie H, Mitragotri S, et al. Polymer particle shape independently influences binding and internalization by macrophages. J Control Rel. 2010;147:408–12.10.1016/j.jconrel.2010.07.116 ↗
45. Champion JA, Mitragotri S. Role of target geometry in phagocytosis. Proc Natl Acad Sci U S A. 2006;103:4930–4.10.1073/pnas.0600997103 ↗
46. Tan J, Shah S, Thomas A, Ou-Yang HD, Liu Y. The influence of size, shape and vessel geometry on nanoparticle distribution. Microfluid Nanofluidics. 2013;14:77–87.10.1007/s10404-012-1024-5 ↗
47. Li Z, Sun L, Zhang Y, Dove AP, O'Reilly RK, Chen G. Shape effect of glyco-nanoparticles on macrophage cellular uptake and immune response. ACS Macro Lett. 2016;5:1059–64.10.1021/acsmacrolett.6b00419 ↗
48. Barua S, Yoo JW, Kolhar P, Wakankar A, Gokarn YR, Mitragotri S. Particle shape enhances specificity of antibody-displaying nanoparticles. Proc Natl Acad Sci U S A. 2013;110:3270–5.10.1073/pnas.1216893110 ↗
49. Xu R, Wang D, Zhang J, Li Y. Shape-dependent catalytic activity of silver nanoparticles for the oxidation of styrene. Chem – An Asian J. 2006;1:888–93.10.1002/asia.200600260 ↗
50. Helmlinger J, Sengstock C, Groß-Heitfeld C, Mayer C, Schildhauer TA, Köller M, et al. Silver nanoparticles with different size and shape: Equal cytotoxicity, but different antibacterial effects. RSC Adv. 2016;6:18490–501.10.1039/C5RA27836H ↗
51. Cheon JY, Kim SJ, Rhee YH, Kwon OH, Park WH. Shape-dependent antimicrobial activities of silver nanoparticles. Int J Nanomed. 2019;14:2773–80.10.2147/IJN.S196472 ↗
52. Arno MC, Inam M, Weems AC, Li Z, Binch A, Platt CI, et al. Exploiting the role of nanoparticle shape in enhancing hydrogel adhesive and mechanical properties. Nat Commun. 2020;11:1–9.10.1038/s41467-020-15206-y ↗
53. Ladj R, Bitar A, Eissa M, Mugnier Y, Le Dantec R, Fessi H, et al. Individual inorganic nanoparticles: Preparation, functionalization and in vitro biomedical diagnostic applications. J Mater Chem B. 2013;1:1381–96.10.1039/c2tb00301e ↗
54. McNamara K, Tofail SAM. Nanosystems: The use of nanoalloys, metallic, bimetallic, and magnetic nanoparticles in biomedical applications. Phys Chem Chem Phys. 2015;17:27981–95.10.1039/C5CP00831J ↗
55. Chakravarty R, Goel S, Dash A, Cai W. Radiolabeled inorganic nanoparticles for positron emission tomography imaging of cancer: An overview. Q J Nucl Med Mol Imaging. 2017;61:181–204.10.23736/S1824-4785.17.02969-7 ↗
56. Patra JK, Das G, Fraceto LF, Campos E, Rodriguez-Torres M, Acosta-Torres LS, et al. Nano based drug delivery systems: Recent developments and future prospects 10 Technology 1007 Nanotechnology 03 Chemical Sciences 0306 Physical Chemistry (incl. Structural) 03 Chemical Sciences 0303 Macromolecular and Materials Chemistry 11 Medical and Health Sciences 1115 Pharmacology and Pharmaceutical Sciences 09 Engineering 0903 Biomedical Engineering Prof Ueli Aebi, Prof Peter Gehr. J Nanobiotechnol. 2018;16:71.10.1186/s12951-018-0392-8 ↗
57. Hong X, Hall EAH. Contribution of gold nanoparticles to the signal amplification in surface plasmon resonance. Analyst. 2012;137:4712–9.10.1039/c2an35742a ↗
58. Dong J, Carpinone PL, Pyrgiotakis G, Demokritou P, Moudgil BM. Synthesis of precision gold nanoparticles using Turkevich method. KONA Powder Part J. 2020;37:224–32.10.14356/kona.2020011 ↗
59. Li J, Li Q, Ma X, Tian B, Li T, Yu J, et al. Biosynthesis of gold nanoparticles by the extreme bacterium – Deinococcus radiodurans – and an evaluation of their antibacterial properties. Int J Nanomed. 2016;11:5931–44.10.2147/IJN.S119618 ↗
60. Kim CK, Ghosh P, Rotello VM. Multimodal drug delivery using gold nanoparticles. Nanoscale. 2009;1:61–7.10.1039/b9nr00112c ↗
61. Li W, Li X, Liu S, Yang W, Pan F, Yang XY, et al. Gold nanoparticles attenuate metastasis by tumor vasculature normalization and epithelial-mesenchymal transition inhibition. Int J Nanomed. 2017;12:12–3509.10.2147/IJN.S128802 ↗
62. Ghersi G. Roles of molecules involved in epithelial/mesenchymal transition during angiogenesis. Front Biosci. 2008;13:2335–55.10.2741/2848 ↗
63. Sulaiman GM, Waheeb HM, Jabir MS, Khazaal SH, Dewir YH, Naidoo Y. Hesperidin loaded on gold nanoparticles as a drug delivery system for a successful biocompatible, anti-cancer, anti-inflammatory and phagocytosis inducer model. Sci Rep. 2020;10:1–16.10.1038/s41598-020-66419-6 ↗
64. Pedrosa P, Corvo ML, Ferreira-Silva M, Martins P, Carvalheiro MC, Costa PM, et al. Targeting cancer resistance via multifunctional gold nanoparticles. Int J Mol Sci. 2019;20:5510.10.3390/ijms20215510 ↗
65. Letfullin RR, Joenathan C, George TF, Zharov VP. Laser-induced explosion of gold nanoparticles: Potential role for nanophotothermolysis of cancer. Nanomedicine. 2006;1:473–80.10.2217/17435889.1.4.473 ↗
66. Zheng Y, Zhang Y, Zhang T, Cai H, Xie X, Yang Y, et al. AuNSs@Glycopolymer-ConA hybrid nanoplatform for photothermal therapy of hepatoma cells. Chem Eng J. 2020;389:124460.10.1016/j.cej.2020.124460 ↗
67. Yang Y, Hu Y, Du H, Ren L, Wang H. Colloidal plasmonic gold nanoparticles and gold nanorings: shape-dependent generation of singlet oxygen and their performance in enhanced photodynamic cancer therapy. Int J Nanomed. 2018;13:2065–78.10.2147/IJN.S156347 ↗
68. Xu X, Chong Y, Liu X, Fu H, Yu C, Huang J, et al. Multifunctional nanotheranostic gold nanocages for photoacoustic imaging guided radio/photodynamic/photothermal synergistic therapy. Acta Biomater. 2019;84:328–38.10.1016/j.actbio.2018.11.043 ↗
69. Tao W, Ziemer KS, Gill HS. Gold nanoparticle-M2e conjugate coformulated with CpG induces protective immunity against influenza A virus. Nanomedicine. 2014;9:237–51.10.2217/nnm.13.58 ↗
70. Bastús NG, Sánchez-Tilló E, Pujals S, Farrera C, Kogan MJ, Giralt E, et al. Peptides conjugated to gold nanoparticles induce macrophage activation. Mol Immunol. 2009;46:743–8.10.1016/j.molimm.2008.08.277 ↗
71. Chen YS, Hung YC, Lin WH, Huang GS, Huang GS. Assessment of gold nanoparticles as a size-dependent vaccine carrier for enhancing the antibody response against synthetic foot-and-mouth disease virus peptide. Nanotechnology. 2010;21:195101. 10.1088/0957-4484/21/19/19510110.1088/0957-4484/21/19/195101 ↗
72. Tazaki T, Tabata K, Ainai A, Ohara Y, Kobayashi S, Ninomiya T, et al. Shape-dependent adjuvanticity of nanoparticle-conjugated RNA adjuvants for intranasal inactivated influenza vaccines. RSC Adv. 2018;8:16527–36.10.1039/C8RA01690A ↗
73. Gulla SK, Rao BR, Moku G, Jinka S, Nimmu NV, Khalid S, et al. In vivo targeting of DNA vaccines to dendritic cells using functionalized gold nanoparticles. Biomater Sci. 2019;7:773–88.10.1039/C8BM01272E ↗
74. Chen TY, Chen MR, Liu SW, Lin JY, Yang YT, Huang HY, et al. Assessment of polyethylene glycol-coated gold nanoparticle toxicity and inflammation in vivo using nf-κb reporter mice. Int J Mol Sci. 2020;21:1–16.10.3390/ijms21218158 ↗
75. Xu M, Liu J, Xu X, et al. Synthesis and comparative biological properties of Ag-PEG nanoparticles with tunable morphologies from Janus to multi-core shell structure. Mater (Basel). 20 September 2018;11. 10.3390/ma11101787.10.3390/ma11101787 ↗
76. Samuel MS, Jose S, Selvarajan E, Mathimani T, Pugazhendhi A. Biosynthesized silver nanoparticles using Bacillus amyloliquefaciens; Application for cytotoxicity effect on A549 cell line and photocatalytic degradation of p-nitrophenol. J Photochem Photobiol B Biol. 2020 Jan;202:111642. 10.1016/j.jphotobiol.2019.111642.10.1016/j.jphotobiol.2019.111642 ↗
77. Pala R, Zeng Y, Pattnaik S, Busi S, Alomari N, Nauli SM, et al. Functionalized silver nanoparticles for sensing, molecular imaging and therapeutic applications. Curr Nanomed. 2019;8:234–50.10.2174/2468187308666180508144919 ↗
78. Abbaszadegan A, Ghahramani Y, Gholami A, Hemmateenejad B, Dorostkar S, Nabavizadeh M, et al. The effect of charge at the surface of silver nanoparticles on antimicrobial activity against gram-positive and gram-negative bacteria: A preliminary study. J Nanomater. 2015;2015:1–8. 10.1155/2015/720654.10.1155/2015/720654 ↗
79. Liao C, Li Y, Tjong SC. Bactericidal and cytotoxic properties of silver nanoparticles. Int J Mol Sci. 2 January 2019;20. 10.3390/ijms20020449.10.3390/ijms20020449 ↗
80. Meikle TG, Dyett BP, Strachan JB, White J, Drummond CJ, Conn CE. Preparation, characterization, and antimicrobial activity of cubosome encapsulated metal nanocrystals. ACS Appl Mater Interfaces. 2020;12:6944–54.10.1021/acsami.9b21783 ↗
81. Hong X, Wen J, Xiong X, Hu Y. Shape effect on the antibacterial activity of silver nanoparticles synthesized via a microwave-assisted method. Env Sci Pollut Res. 2016;23:4489–97.10.1007/s11356-015-5668-z ↗
82. Raza MA, Kanwal Z, Rauf A, Sabri AN, Riaz S, Naseem S. Size- and shape-dependent antibacterial studies of silver nanoparticles synthesized by wet chemical routes. Nanomaterials. 2016;6:74.10.3390/nano6040074 ↗
83. Shanmuganathan R, MubarakAli D, Prabakar D, Muthukumar H, Thajuddin N, Kumar SS, et al. An enhancement of antimicrobial efficacy of biogenic and ceftriaxone-conjugated silver nanoparticles: green approach. Env Sci Pollut Res. 2018;25:10362–70.10.1007/s11356-017-9367-9 ↗
84. Yu L, Shang F, Chen X, Ni J, Yu L, Zhang M, et al. The anti-biofilm effect of silvernanoparticle-decorated quercetin nanoparticles on a multi-drug resistant Escherichia coli strain isolated from a dairy cow with mastitis. PeerJ. 2018;2018:e5711.10.7717/peerj.5711 ↗
85. Siddique MH, Aslam B, Imran M, Ashraf A, Nadeem H, Hayat S, et al. Effect of silver nanoparticles on biofilm formation and eps production of multidrug-resistant Klebsiella pneumoniae. Biomed Res Int. 2020;2020:6398165. 10.1155/2020/6398165.10.1155/2020/6398165 ↗
86. Salleh A, Naomi R, Utami ND, Mohammad AW, Mahmoudi E, Mustafa N, et al. The potential of silver nanoparticles for antiviral and antibacterial applications: a mechanism of action. Nanomaterials. 2020;10:1566.10.3390/nano10081566 ↗
87. Elechiguerra JL, Burt JL, Morones JR, Camacho-Bragado A, Gao X, Lara HH, et al. Interaction of silver nanoparticles with HIV-1. J Nanobiotechnol. 2005;3:6.10.1186/1477-3155-3-6 ↗
88. Lara HH, Ayala-Nuñez NV, Ixtepan-Turrent L, Rodriguez-Padilla C. Mode of antiviral action of silver nanoparticles against HIV-1. J Nanobiotechnol. 2010;8:1.10.1186/1477-3155-8-1 ↗
89. Tsai CH, Whiteley CG, Lee DJ. Interactions between HIV-1 protease, silver nanoparticles, and specific peptides. J Taiwan Inst Chem Eng. 2019;103:20–32.10.1016/j.jtice.2019.07.019 ↗
90. Morris D, Ansar M, Speshock J, Ivanciuc T, Qu Y, Casola A, et al. Antiviral and immunomodulatory activity of silver nanoparticles in experimental RSV infection. Viruses. 2019;11:732.10.3390/v11080732 ↗
91. Jeremiah SS, Miyakawa K, Morita T, Yamaoka Y, Ryo A. Potent antiviral effect of silver nanoparticles on SARS-CoV-2. Biochem Biophys Res Commun. 2020;533:195–200.10.1016/j.bbrc.2020.09.018 ↗
92. Balagna C, Perero S, Percivalle E, Nepita EV, Ferraris M. Virucidal effect against coronavirus SARS-CoV-2 of a silver nanocluster/silica composite sputtered coating. Open Ceram. 2020;1:100006.10.1016/j.oceram.2020.100006 ↗
93. Hsin Y-H, Chen C-F, Huang S, Shih TS, Lai PS, Chueh PJ. The apoptotic effect of nanosilver is mediated by a ROS- and JNK-dependent mechanism involving the mitochondrial pathway in NIH3T3 cells. Toxicol Lett. 2008;179:130–9.10.1016/j.toxlet.2008.04.015 ↗
94. Sriram MI, Kanth SB, Kalishwaralal K, Gurunathan S. Antitumor activity of silver nanoparticles in Dalton’s lymphoma ascites tumor model. Int J Nanomed. 2010;5:753–62.10.2147/IJN.S11727 ↗
95. Perde-Schrepler M, Florea A, Brie I, Virag P, Fischer-Fodor E, Vâlcan A, et al. Size-dependent cytotoxicity and genotoxicity of silver nanoparticles in cochlear cells in vitro. J Nanomater. 2019;2019:1–12. 10.1155/2019/6090259.10.1155/2019/6090259 ↗
96. Farzin A, Etesami SA, Quint J, Memic A, Tamayol A. Magnetic nanoparticles in cancer therapy and diagnosis. Adv Healthc Mater. 2020;9:e1901058.10.1002/adhm.201901058 ↗
97. Ali A, Shah T, Ullah R, Zhou P, Guo M, Ovais M, et al. Review on recent progress in magnetic nanoparticles: synthesis, characterization, and diverse applications. Front Chem. 2021;9:548.10.3389/fchem.2021.629054 ↗
98. Li X, Lovell JF, Yoon J, Chen X. Clinical development and potential of photothermal and photodynamic therapies for cancer. Nat Rev Clin Oncol. 2020;2020(17):657–74.10.1038/s41571-020-0410-2 ↗
99. Wang X, Yang R, Yuan C, An Y, Tang Q, Chen D. Preparation of folic acid-targeted temperature-sensitive magnetoliposomes and their antitumor effects in vitro and in vivo. Target Oncol. 2018;13:481–94.10.1007/s11523-018-0577-y ↗
100. Huang G, Chen H, Dong Y, Luo X, Yu H, Moore Z, et al. Superparamagnetic iron oxide nanoparticles: amplifying ROS stress to improve anticancer drug efficacy. Theranostics. 2013;3:116–26.10.7150/thno.5411 ↗